Why the study?
Do embolic protection devices prevent neurological complications and silent ischemic brain lesions in patients undergoing TAVR?
Population
Patients with severe aortic valve stenosis undergoing transcatheter aortic valve replacement (TAVR)
Design
Review
Authors
Loading...
Does not support routine EPD use in TAVR; leaves open whether MRI lesion reduction improves clinical outcomes.
Do embolic protection devices prevent neurological complications and silent ischemic brain lesions in patients undergoing TAVR?
Current evidence indicates that while embolic protection devices during TAVR reduce the volume of silent ischemic brain lesions on MRI, they have not yet been shown to reduce the incidence of clinical neurological events.
Gallo et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: